Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.004 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Aging of the nitric oxide system: are we as old as our NO?Sverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Horowitz, J.
2013Premature aging of cardiovascular/platelet function in polycystic ovarian syndromeChan, W.; Ngo, D.; Sverdlov, A.; Rajendran, S.; Stafford, I.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.
2013Enhanced NO signaling in patients with Takotsubo cardiomyopathy: short-term pain, long-term gain?Nguyen, T.; Neil, C.; Sverdlov, A.; Ngo, D.; Chan, W.; Heresztyn, T.; Chirkov, Y.; Tsikas, D.; Frenneaux, M.; Horowitz, J.
2013Reciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapySverdlov, A.; Chan, W.; Procter, N.; Chirkov, Y.; Ngo, D.; Horowitz, J.
2012Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeuticsSverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Gersh, B.; McNeil, J.; Horowitz, J.
2011Determinants of insulin responsiveness in young women: Impact of polycystic ovarian syndrome, nitric oxide, and vitamin DNgo, D.; Chan, W.; Rajendran, S.; Heresztyn, T.; Amarasekera, A.; Sverdlov, A.; O'Loughlin, P.; Morris, H.; Chirkov, Y.; Norman, R.; Horowitz, J.
2014Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesChong, C.; Chan, W.; Nguyen, T.; Liu, S.; Procter, N.; Ngo, D.; Sverdlov, A.; Chirkov, Y.; Horowitz, J.
2014Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeuticsProcter, N.; Chong, C.; Sverdlov, A.; Chan, W.; Chirkov, Y.; Horowitz, J.
2012Ramipril sensitizes platelets to nitric oxide: Implications for therapy in high-risk patientsWilloughby, S.; Rajendran, S.; Chan, W.; Procter, N.; Leslie, S.; Liberts, E.; Heresztyn, T.; Chirkov, Y.; Horowitz, J.